Hengrui Pharma Gets China Clinical Trial Approval for 10 Anti-Tumor Drugs MT Sep. 21 Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug MT Sep. 21 Hengrui Pharmaceuticals Gets ...
Chirinos noted that these abuses are documented in reports by human rights organizations and in investigations by the UN ...
Medicare may not provide things entirely "for free," but some items and services are covered with no out-of-pocket costs under specific conditions.
Kevin Mortimer has been described as a 'super responder' to triplet therapy - a method that attacks the cancer with three ...
Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...
Jiangsu Hengrui Medicine Co. Ltd. published this content on October 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and ...
Radiation therapy (RT) and radical prostatectomy (RP) have distinct morbidity profiles that support individualized treatment ...
"Lately, they seem a bit low on energy..." "I feel like they spend more time just staring into space..."Such changes in elderly family members or residents living in facilities are often secretly caus ...
Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it? Dr Shashank MS ...
But modern life seems to be speeding up the clock, with rates of prostate, bowel, kidney and womb cancer doubling among the under-50s over the last 25 years, while liver, pancreatic and breast cance r ...
Learn about prostate cancer risks, warning signs, and the importance of early detection and PSA screening for effective ...
A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results